Researchers from the University of the Witswatersrand (Wits) have announced that CAB LA injections, taken once every eight weeks, are more effective in preventing HIV in women in sub-Saharan Africa, compared with the daily TDF/FTC pill that is currently being used. These are the results of the NPTN trial, which have been touted as a milestone for prevention of HIV among women and as motivation for further studies.
from Engineering News | Home https://ift.tt/2GOgYkj
